Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
|
Mid-range Performer
656.2000
-20.85
(
-3.08
%)
NSE
Apr 02, 2026
15:31 PM
Near 52W Low of ₹635.80
Volume:
60,922
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
12 Feb 2025
656.20
-3.08%
Alembic Pharma (BUY): Earnings recovery on normalised Azithromycin base
Buy:
Alembic Pharmaceuticals Ltd.
by
BOB Capital Markets Ltd.
Target: 1032
Target
BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharma has lost
-27.92%
in the last 6 Months
More from Alembic Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - April 2, 2026
The Baseline |
02 Apr 2026
Market closes higher on strong rupee and value buying
Trendlyne Marketwatch |
02 Apr 2026
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020